| ?? |
?? ?? |
CAS |
MF |
 |
Ascorbic acid EP Impurity G (L-threo-Hex-2-eneric acid, 1-4-lactone) |
66757-69-5 |
C6H6O7 |
 |
Formoterol EP Impurity F |
1795129-59-7 |
C37H46N4O6 |
 |
Peramivir Impurity 1 |
1988779-13-0 |
C18H34N2O5 |
 |
Trillikamtoside Q |
2098642-70-5 |
C49H72O25 |
 |
??????????13 |
874760-71-1 |
C13H13N3O6 |
 |
Paliperidone Impurity 7 |
1415488-05-9 |
C27H45ClN2O3 |
 |
??????????A |
59865-15-5 |
C62H113N11O12 |
 |
N-ACETYLNEURAMIN-LACTOSE |
35890-39-2 |
C23H39NO19 |
![8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one](/CAS/20200331/GIF/2204863-06-7.gif) |
8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one |
2204863-06-7 |
C24H29N7O |
 |
Irinotecan Impurity 18 |
1255644-71-3 |
C33H38N4O6 |
 |
Erythromycin Impurity 9 |
58781-38-7 |
C38H63NO13 |
 |
Rasagiline Dipropynyl HCl |
92850-02-7 |
C15H15N |
 |
Bortezomib Impurity Z |
|
|
|
|
Bortezomib Impurity Z |
|
|
|
|
Cilastatin Impurity B |
|
|
 |
Brivaracetam Impurity 21 |
63095-60-3 |
C7H12O2 |
 |
Afatinib Impurity des-EJA |
2223677-64-1 |
C22H20ClFN4O3 |
 |
Parecoxib Sodium EJF |
2338845-31-9 |
C32H24N2O4S |
|
|
Deferasirox Impurity 13 |
|
|
 |
Doxofylline iMpurity D |
67236-15-1 |
C19H28ClNO3 |
 |
N-?????????????????? |
73058-37-4 |
C15H15N3O3 |
 |
Piperacillin impurity 8/Piperacillin Dimer impurity 3 |
2170771-53-4 |
C46H54N10O14S2 |
 |
Demeclocycline Impurity E(EP) |
22756-01-0 |
C21H20N2O7 |
 |
rac-Ibuprofen amide |
59512-17-3 |
C13H19NO |
![D-glycero-Heptaric acid, 2,4,6-trideoxy-2-[(1R)-1-hydroxyethyl]-6-imino-5-S-[2-[(iminomethyl)amino]ethyl]-5-thio-, 7,3-lactone, (3ξ,5ξ)-](/CAS/20211123/GIF/1193105-97-3.gif) |
D-glycero-Heptaric acid, 2,4,6-trideoxy-2-[(1R)-1-hydroxyethyl]-6-imino-5-S-[2-[(iminomethyl)amino]ethyl]-5-thio-, 7,3-lactone, (3ξ,5ξ)- |
1193105-97-3 |
C12H19N3O5S |
![1H-Imidazole-5-carboxylic acid, 1-methyl-4-[methyl[[(5-oxohexyl)amino]carbonyl]amino]-](/CAS/20210111/GIF/84321-40-4.gif) |
1H-Imidazole-5-carboxylic acid, 1-methyl-4-[methyl[[(5-oxohexyl)amino]carbonyl]amino]- |
84321-40-4 |
C13H20N4O4 |
 |
1H-Imidazole-5-carboxamide, 1-methyl-4-(methylamino)-N-(5-oxohexyl)- |
70486-28-1 |
C12H20N4O2 |
 |
3-chloro-N,N-dimethyl-1-phenylpropan-1-amine hydrochloride |
81402-53-1 |
C11H17Cl2N |
|
|
Montelukast sodium EP Impurity J |
|
|
 |
2,3-????-2-??-1H-??-1-??????????? |
85392-00-3 |
C10H16N2O3S |
 |
Butanoic acid, 2,4-dicyano-3-oxo-, ethyl ester |
861612-04-6 |
C8H8N2O3 |
 |
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(4-fluorophenyl)-4-(hydroxymethyl)-1-(1H-1,2,4-triazol-1-yl)- |
1978305-26-8 |
C14H16FN3O2 |
![5-[??(2-??????)???]??-2-?](/CAS/GIF/74509-79-8.gif) |
5-[??(2-??????)???]??-2-? |
74509-79-8 |
C9H19NO2 |
|
|
Impurity reference substance |
|
|
 |
(2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane |
119302-24-8 |
C29H48N2O4 |
 |
Bromhexine Glucose Compound 1 |
3049873-97-1 |
C20H30Br2N2O5 |
 |
2-???-1-(4-??????)???-1-? |
80336-66-9 |
C13H17ClO |
 |
Omeprazole EP Impurity F |
125656-82-8 |
C16H13N3O2S |
 |
1-METHYL-6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINE???? |
27740-96-1 |
C10H13NO2 |
 |
????X |
525-91-7 |
C16H18N2O5S |
 |
???????B |
143601-09-6 |
C21H24O11 |
 |
taspine |
602-07-3 |
C20H19NO6 |
 |
????I |
51415-00-0 |
C17H16O4 |
 |
(-)-4-(4-??????)-1-(4-??????)-1-(??????)-3-??????)-???????D-(+)-?-p-????????? |
128173-53-5 |
2C20H23FN2O2.C20H18O8 |
 |
(3,4-??????)???? |
5635-67-6 |
C8H9Cl2N |
 |
N-Desmethyl Dapoxetine |
157166-71-7 |
C20H22ClNO |
 |
???? |
602-85-7 |
C16H18N2O |
![(1β,5β)-8-Methyl-8-azabicyclo[3.2.1]octa-6-ene-3α-ol](/CAS/20180808/GIF/20513-09-1.gif) |
(1β,5β)-8-Methyl-8-azabicyclo[3.2.1]octa-6-ene-3α-ol |
20513-09-1 |
C8H13NO |
 |
N-??-5-?????-1H-????-4-??????? |
6736-40-9 |
C6H10N4O |
 |
(R)-(-)-??? |
10403-00-6 |
C16H30O |
 |
3-?????????? |
916982-10-0 |
C9H15NO2 |
 |
?????????? |
1217245-60-7 |
C18H29NO3 |
 |
6α-??????????? |
87585-03-3 |
C21H28O3 |
 |
FaMotidine???? |
107880-74-0 |
C8H12N4O2S2 |
 |
N-????-N-???BuMetanide |
28395-28-0 |
C16H18N2O5S |
 |
(1S,2S,3S,4R)-Methyl 3-((R)-1-aMino-2-ethylbutyl)-4-(tert-butoxycarbonylaMino)-2-hydroxycyclopentanecarboxylate |
316173-29-2 |
C18H34N2O5 |
??}-5,5-????????-4-?????,?????)](/CAS/GIF/68728-47-2.gif) |
??????????D(50mg)((4S)-2-{[(R)-2-???-2-(4-??????)??????](????)??}-5,5-????????-4-?????,?????) |
68728-47-2 |
C16H20N3NaO6S |
![?????????????D(25mg)(3-[2-(2-????????)?????]????????????)](/CAS/20180808/GIF/158401-51-5.gif) |
?????????????D(25mg)(3-[2-(2-????????)?????]????????????) |
158401-51-5 |
C7H19Cl2N2O4P |
 |
3-Quinolinecarboxylic acid, 7-aMino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- |
172426-88-9 |
C14H13FN2O4 |
 |
EsoMeprazole????H431/41 |
1227380-90-6 |
C16H15N3O4 |
 |
????EP???C |
49841-96-5 |
C16H19N3O4S |
 |
9β,10α-Pregna-4,6,8(14)-triene-3,20-dione |
23035-53-2 |
C21H26O2 |
 |
N-(3,4-???????)-4-(4-?????)??-2-?? |
61413-44-3 |
C21H29NO3 |
 |
Dabigatran Etexilate iMpurity H |
1702936-92-2 |
C19H20N4O3 |
 |
RebaMipide3-Chloro??? |
90098-05-8 |
C19H15ClN2O4 |
 |
Solifenacin IMpurity |
1956436-64-8 |
C23H26N2O3 |
 |
???????γ-?????? |
67022-39-3 |
C21H24N8O5 |
 |
RebaMipide iMpurity 1 |
100342-53-8 |
C18H15ClN2O2 |
![7-?????[b]???-3-???](/CAS/20150408/GIF/142181-53-1.gif) |
7-?????[b]???-3-??? |
142181-53-1 |
C9H7ClOS |
 |
N,5-bis(4-chlorophenyl)-3-iMino-3,5-dihydrophenazin-2-aMine |
102262-55-5 |
C24H16Cl2N4 |
 |
Milnacipran Related Impurity 3 |
19532-98-0 |
C10H12N2O2 |
 |
1,1'-??????-????? |
74857-22-0 |
C17H20N8O4 |
 |
Salbutamol EP Impurity D |
|
C13H21NO3 |
 |
Atazanavir EP Impurity G |
1332981-16-4 |
C38H52N6O7 |
|
|
Olaparib Impurity G |
|
|
 |
Brivaracetam Impurity B |
943986-67-2 |
C11H19NO3 |
|
|
Rufinamide Impurity 3 |
|
|
 |
2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid |
74936-81-5 |
C15H14N2O6 |
 |
Apixaban Impurity 24 |
1928718-22-2 |
C26H27N5O4 |
|
|
Cisatracurium Besilate impurity |
|
|
 |
Azithromycin F |
612069-26-8 |
C38H72N2O13 |
![[D-PRO2,D-TRP7,9]-??P](/CAS/GIF/80434-86-2.gif) |
[D-PRO2,D-TRP7,9]-??P |
80434-86-2 |
C74H106N20O13S |
 |
?? |
17429-69-5 |
C28H32O17 |
 |
1-(4-Bromobutyl)-3,4-dihydro-7-hydroxy-2(1H)-quinolinone |
1424857-68-0 |
C13H16BrNO2 |
 |
Pitavastatin |
154170-27-1 |
C32H36FNO4 |
 |
Famotidine EP Impurity A |
124646-10-2 |
C8H14N6S2 |
 |
2-(azidomethyl)-1,3-difluorobenzene |
106308-60-5 |
C7H5F2N3 |
 |
sobutyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5 -carboxylate |
923942-36-3 |
C20H24N2O3S |
![(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid](/CAS/20200401/GIF/927820-48-2.gif) |
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
 |
Rivaroxaban Related Compound (R-4-(4-(5-(Aminomethyl)-2-Oxooxazolidin-3-yl)phenyl-Morpholin-3-One HCl) |
1429311-47-6 |
C14H18ClN3O4 |
 |
Cefprozil EP Impurity I |
|
C18H19N3O5S |
 |
ethyl 2-(4-butoxy-3-formylphenyl)-4-methylthiazole-5-
carboxylate |
2230270-03-6 |
C18H21NO4S |
 |
1H-Pyrazole-3-Carboxylicacid,4,5-Dihydro-5-Oxo-1-(4-Sulfophenyl)-,3-Ethylester,Sodiumsalt |
20514-27-6 |
C12H13N2NaO6S |
 |
((3S,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethyl
sulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate) calcium(II) |
2185805-14-3 |
C44H54CaF2N6O12S2 |
 |
Lincomycin EP Impurity C |
14600-41-0 |
C17H32N2O6S.ClH |
 |
Peramivir Impurity |
383910-24-5 |
C18H30N2O5 |
 |
N-SucciniMidoxycarbonyl-β-alanine N-SucciniMidyl Ester |
21994-89-8 |
C12H13N3O8 |
|
|
Cefotaxime Impurity L |
|
|
 |
(2RS)-2-(4-?????)???? |
43153-07-7 |
C10H10O3 |
 |
Apremilast Impurity HS093313 |
2077897-93-7 |
C20H21NO6S |